Recent Advances and Future Perspectives in Mitigating Invasive Antifungal-Resistant Pathogen Aspergillus fumigatus in Africa

Friedman DZP, Schwartz IS. Emerging fungal infections: new patients, new patterns, and new pathogens. J Fungi. 2019;5:67.

Article  CAS  Google Scholar 

Brown GD, Denning DW, Gow NAR, Levitz SM, Netea MG, White TC. Hidden killers: human fungal infections. Sci Transl Med. 2012;4

Bongomin F, Gago S, Oladele RO, Denning DW. Global and multi-national prevalence of fungal diseases - estimate precision. J Fungi. 2017:3.

Samrah S, Sweidan A, Aleshawi A, Ayesh M. Fusarium-induced cellulitis in an immunocompetent patient with sickle cell disease: a case report. J Investig Med High Impact Case Rep. 2020:8.

Bellanger AP, Navellou JC, Lepiller Q, Brion A, Brunel AS, Millon L, et al. Mixed mold infection with Aspergillus fumigatus and Rhizopus microsporus in a severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) patient. Infectious Diseases Now. 2021;51:633.

PubMed  PubMed Central  Google Scholar 

Truda VSS, Falci DR, Porfírio FMV, de Santos DW Junior FI, Pasqualotto AC, et al. A contemporary investigation of burden and natural history of aspergillosis in people living with HIV/AIDS. Mycoses 2023

Song G, Liang G, Liu W. Fungal co-infections associated with global COVID-19 pandemic: a clinical and diagnostic perspective from China. Mycopathologia. 2020;185:599–606.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bhatt K, Agolli A, Patel MH, Garimella R, Devi M, Garcia E, et al. High mortality co-infections of COVID-19 patients: mucormycosis and other fungal infections. Discoveries. 2021;9:e126.

Article  PubMed  PubMed Central  Google Scholar 

Rodrigues ML, Nosanchuk JD. Fungal diseases as neglected pathogens: a wake-up call to public health officials. PLoS Negl Trop Dis. 2020;14

WHO. First meeting of the WHO antifungal expert group on identifying priority fungal pathogens. 2020.

Google Scholar 

WHO. WHO fungal priority pathogens list to guide research development and public health. World Health Organization; 2022. p. 1–48. An outstanding document that systematically prioritizes fungal pathogens with the goal of guiding future research and policy changes to improve the global response to fungal infections and antifungal resistance.

Google Scholar 

Driemeyer C, Falci DR, Oladele RO, Bongomin F, Ocansey BK, Govender NP, et al. The current state of clinical mycology in Africa: a European Confederation of Medical Mycology and International Society for Human and Animal Mycology survey. The Lancet Microbe. 2022;

WHO. WHO guidelines for the diagnosis, prevention and management of cryptococcal disease; 2018. p. 1–62.

Google Scholar 

Nasir I, Shuwa H, Emeribe A, Adekola H, Dangana A. Phenotypic profile of pulmonary aspergillosis and associated cellular immunity among people living with human immunodeficiency virus in Maiduguri, Nigeria. Tzu-Chi Medical Journal. 2019;31:153.

Google Scholar 

Wiederhold NP. Antifungal resistance: current trends and future strategies to combat. Infect Drug Resist. 2017;10:259.

Article  Google Scholar 

Wiederhold NP. Emerging fungal infections: new species, new names, and antifungal resistance. Clin Chem. 2022;68:90.

Google Scholar 

Campbell CA, Osaigbovo II, Oladele RO. Triazole susceptibility of Aspergillus species: environmental survey in Lagos, Nigeria and review of the rest of Africa. Ther Adv Infect Dis. 2021;8:20499361211044330.

PubMed  PubMed Central  Google Scholar 

Fisher MC, Hawkins NJ, Sanglard D, Gurr SJ. Worldwide emergence of resistance to antifungal drugs challenges human health and food security. Science. 2018;360:739–42.

Article  PubMed  CAS  Google Scholar 

Hendrickson JA, Hu C, Aitken SL, Beyda N. Antifungal resistance: a concerning trend for the present and future. Curr Infect Dis Rep. 2019;21:1–8.

Article  Google Scholar 

Rodrigues CF, Henriques M. Oral mucositis caused by Candida glabrata biofilms: failure of the concomitant use of fluconazole and ascorbic acid. Ther Adv Infect Dis. 2017;4:10–7.

PubMed  PubMed Central  CAS  Google Scholar 

Bhattacharya S, Sae-Tia S, Fries BC. Candidiasis and mechanisms of antifungal resistance. Antibiotics. 2020;9:312.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Rybak JM, Cuomo CA, David RP. The molecular and genetic basis of antifungal resistance in the emerging fungal pathogen Candida auris. Curr Opin Microbiol. 2022;70:102208.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wang Q, Lei C, Cheng H, Yang X, Huang Z, Chen X, et al. Widespread dissemination of plasmid-mediated tigecycline resistance gene tet (X4) in Enterobacterales of porcine origin. Microbiol Spectr. 2022;10:e01615–22.

PubMed  PubMed Central  Google Scholar 

Rhodes J, Abdolrasouli A, Dunne K, Sewell TR, Zhang Y, Ballard E, et al. Population genomics confirms acquisition of drug-resistant Aspergillus fumigatus infection by humans from the environment. Nat Microbiol. 2022;7:663–74.

Article  PubMed  PubMed Central  CAS  Google Scholar 

O’brien B, Chaturvedi S, Chaturvedi V. In vitro evaluation of antifungal drug combinations against multidrug-resistant Candida auris isolates from New York outbreak. Antimicrob Agents Chemother. 2020;64:e02195–19.

PubMed  Google Scholar 

Oladele R, Uwanibe JN, Olawoye IB, Ettu AWO, Meis JF, Happi CT. Emergence and genomic characterization of multidrug resistant Candida auris in Nigeria, West Africa. J Fungi. 2022;8:787. The authors of this study used whole-genome sequencing (WGS) to identify the emerging multidrug-resistant fungal pathogens. The study is important for public health because it highlights the need for active disease surveillance in Africa as well as diagnostic gaps in healthcare settings.

Article  CAS  Google Scholar 

Lestrade PP, Bentvelsen RG, Schauwvlieghe AFAD, Schalekamp S, Van Der Velden WJFM, Kuiper EJ, et al. Voriconazole resistance and mortality in invasive aspergillosis: a multicenter retrospective cohort study. Clin Infect Dis. 2019;68:1463–71.

Article  PubMed  CAS  Google Scholar 

Chen J, Li H, Li R, Bu D, Wan Z. Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma. J Antimicrob Chemother. 2005;55:31–7.

Article  PubMed  CAS  Google Scholar 

Chen P, Liu M, Zeng Q, Zhang Z, Liu W, Sang H, et al. Uncovering new mutations conferring azole resistance in the Aspergillus fumigatus cyp51A gene. Front Microbiol. 2020;10:3127–38.

Article  PubMed  PubMed Central  Google Scholar 

Salehi Z, Sharifynia S, Jamzivar F, Shams-Ghahfarokhi M, Poorabdollah M, Abtahian Z, et al. Clinical epidemiology of pulmonary aspergillosis in hospitalized patients and contribution of Cyp51A, Yap1, and Cdr1B mutations to voriconazole resistance in etiologic Aspergillus species. Eur J Clin Microbiol Infect Dis. 2023;2023:1–12.

Google Scholar 

Fang W, Wu J, Cheng M, Zhu X, Du M, Chen C, et al. Diagnosis of invasive fungal infections: challenges and recent developments. J Biomed Sci. 2023;30:42.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Fosses Vuong M, Hollingshead CM, Waymack JR. Aspergillosis. Treasure Island (FL): StatPearls; 2023. http://www.ncbi.nlm.nih.gov/books/NBK482241/. Accessed 11 Sep 2023

Google Scholar 

Danion F, Rouzaud C, Duréault A, Poirée S, Bougnoux M-E, Alanio A, et al. Why are so many cases of invasive aspergillosis missed? Med Mycol. 2019;57:S94–103.

Article  PubMed  CAS  Google Scholar 

Rasheed W, Tasnim S, Dweik A, Al-Jabory O, Usala S. Allergic bronchopulmonary aspergillosis (ABPA) diagnosis missed in the context of asthma exacerbation due to medication nonadherence. Cureus. 2022;14:e28202.

PubMed  PubMed Central  Google Scholar 

Denham ST, Wambaugh MA, Brown JCS. How environmental fungi cause a range of clinical outcomes in susceptible hosts. J Mol Biol. 2019;431:2982–3009.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Banerjee S, Denning DW, Chakrabarti A. One Health aspects & priority roadmap for fungal diseases : a mini-review. Indian J Med Res. 2021;153:311–9.

Article  PubMed  PubMed Central  Google Scholar 

Guarner J, Brandt ME. Histopathologic diagnosis of fungal infections in the 21st century. Clin Microbiol Rev. 2011;24:247–80.

Article  PubMed  PubMed Central  Google Scholar 

Sangoi AR, Rogers WM, Longacre TA, Montoya JG, Baron EJ, Banaei N. Challenges and pitfalls of morphologic identification of fungal infections in histologic and cytologic specimens: a ten-year retrospective review at a single institution. Am J Clin Pathol. 2009;131:364–75.

Article  PubMed  Google Scholar 

Lee S, Yun NR, Kim K-H, Jeon JH, Kim E-C, Chung DH, et al. Discrepancy between histology and culture in filamentous fungal infections. Med Mycol. 2010;48:886–8.

Article  PubMed  Google Scholar 

Shah AA, Hazen KC. Diagnostic Accuracy of Histopathologic and cytopathologic examination of aspergillus species. Am J Clin Pathol. 2013;139:55–61.

Article  PubMed  Google Scholar 

Arvanitis M, Anagnostou T, Fuchs BB, Caliendo AM, Mylonakis E. Molecular and nonmolecular diagnostic methods for invasive fungal infections. Clin Microbiol Rev. 2014;27:490–526.

Article  PubMed  PubMed Central  Google Scholar 

Bassetti M, Peghin M, Vena A. Challenges and solution of invasive aspergillosis in non-neutropenic patients: a review. Infect Dis Ther. 2018;7:17–27.

Article  PubMed  Google Scholar 

Russo A, Tiseo G, Falcone M, Menichetti F. Pulmonary aspergillosis: an evolving challenge for diagnosis and treatment. Infect Dis Ther. 2020;9:511–24.

Article  PubMed  PubMed Central  Google Scholar 

Negroni R. Onychomycosis due to aspergillus species. In: Comarú Pasqualotto A, editor. Aspergillosis: From Diagnosis to Prevention. Dordrecht: Springer Netherlands; 2010. p. 961–71. https://doi.org/10.1007/978-90-481-2408-4_56.

Chapter  Google Scholar 

Bongomin F, Batac CR, Richardson MD, Denning DW. A review of onychomycosis due to aspergillus species. Mycopathologia. 2018;183:485–93.

Article  PubMed  Google Scholar 

Chakrabarti A, Chatterjee S, Radotra BD. Cutaneous and wound aspergillosis. In: Comarú Pasqualotto A, editor. Aspergillosis: From Diagnosis to Prevention. Dordrecht: Springer Netherlands; 2010. p. 939–59. https://doi.org/10.1007/978-90-481-2408-4_55.

Chapter  Google Scholar 

Bongomin F, Asio LG, Baluku JB, Kwizera R, Denning DW. Chronic pulmonary aspergillosis: notes for a clinician in a resource-limited setting where there is no mycologist. J Fungi (Basel). 2020;6:75. An excellent review that highlights the crucial knowledge needed by a non-specialist mycologist or clinician in a resource-constrained setting to diagnose and treat chronic pulmonary aspergillosis (CPA), which is brought on by Aspergillus species in immunocomp

留言 (0)

沒有登入
gif